Announcements
- Participation in Upcoming Investor Conference
- MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference
- Signing of Strategic Platform License
- MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
- Holding(s) in Company
- Filing of Form 10-Q
- First Quarter Results
- MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
- Notice of AGM
- Total Voting Rights
More ▼
Key statistics
On Friday, MaxCyte Inc (MYE0:MUN) closed at 4.22, -12.81% below its 52-week high of 4.84, set on Jan 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.22 |
---|---|
High | 4.22 |
Low | 4.22 |
Bid | 4.08 |
Offer | 4.22 |
Previous close | 4.22 |
Average volume | 0.00 |
---|---|
Shares outstanding | 104.54m |
Free float | 98.13m |
P/E (TTM) | -- |
Market cap | 468.36m USD |
EPS (TTM) | -0.3532 USD |
Data delayed at least 15 minutes, as of May 31 2024 07:15 BST.
More ▼